BUILDING ON TRUST AND COLLABORATION TO ROADMAP NEXT PHASE OF AUSTRALIA’S VACCINE SUCCESS Conference returns to lead charge in strengthening the entire life cycle of vaccine development
With
Leah Goodman
Chief Executive Officer
Biointelect
SEGMENT
Filmed in Sydney | September 2026
Trust, collaboration and a stronger vaccine ecosystem were the focus of the second Australian Vaccine Value Chain Conference, held in Sydney, September 2026 and hosted by life science consultancy Biointelect. More than 200 leaders from government, industry, academia, research, investment and the immunisation community attended, joined by international representatives including the International Vaccine Institute and the Coalition for Epidemic Preparedness Innovations.
The conference took place amid falling global immunisation rates, rising misinformation, shrinking funding and a resurgence of measles. In Australia, childhood immunisation rates have fallen by between 2.3 and 4.3 percentage points at standard age milestones each year since 2020. Discussions covered research funding, regional health security, sovereign manufacturing, data and capacity building, vaccine access, uptake resistance and pandemic preparedness. Delegates noted progress through the new Australian Centre for Disease Control and the updated National Immunisation Strategy, but experts say further action is needed.
In an interview with the Australian Health Journal, Biointelect CEO Leah Goodman said the mood had shifted since the inaugural 2024 conference, when nervousness was evident. This year, she said, attendees were “feeling that they had a role to play in the shaping of the Australian ecosystem.” She pointed to the first six companies announced in the Biointelect Venturer incubator, funded through the Medical Research Future Fund, as a sign of progress.
Goodman also stressed the importance of international cooperation, stating that “no country can build a resilient vaccine ecosystem alone.” A white paper will capture the discussions and set priorities for the next two years.
Source: Adapted from Biointelect media release (September 2026) and transcript
-
Alfred Hospital leading in pharmacy services for critically unwell patients
Cristina Roman, is the Lead Pharmacist at Alfred Emergency Trauma Centre. In her 12 years working in the Emergency Department, Cristina has established pharmacy services, and filled gaps in patient care with new models of care.
One of those models of care adopted by the US and other countries, is involving pharmacists for critically unwell patients that present to the emergency department.
Australian Health Journal spoke with Cristina Roman and Lisa Bremner, Advanced Training Resident Pharmacist at Alfred Hospital Emergency Trauma Centre.
-
Medical research institutes association responds to draft national research strategy
On 27 August 2025, the Minister for Health, Disability and Ageing announced the release of the draft National Health and Medical Research Strategy (the National Strategy).
Involved in the initial consultation phase, was the Association of Australian Medical Research Institutes (AAMRI), the peak body for medical research institutes across Australia. Member institutes work on a broad spectrum of human health issues such as preventive health, chronic disease, mental health, immunology and Indigenous health. Their research ranges from fundamental biomedical discovery through to clinical research and the translation of research findings.
-
Improvements in dental literacy and greater clinical insights through digital technology
Dr. Kenneth Soh is a General Dentist based in Kellyville, New South Wales, a suburb located in northwestern Sydney. Originally from Melbourne, he studied Bachelor of Dental Science (BDSc) at Melbourne University and graduated in 2003. After working for a year in the Mornington Peninsula, Dr. Soh moved to New South Wales, initially thinking it would be temporary; however, he has been there for 19 years. While he has considered specialising, he finds joy in all aspects of dentistry.
